4//SEC Filing
ONCOGENEX PHARMACEUTICALS, INC. 4
Accession 0001209191-17-039846
$ACHVCIK 0000949858operating
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 4:39 PM ET
Size
13.3 KB
Accession
0001209191-17-039846
Insider Transaction Report
Form 4
Cormack Scott Daniel
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2017-06-12+5,000→ 89,055 total(indirect: By Spouse) - Exercise/Conversion
Restricted Stock Unit (RSU)
2017-06-12−5,000→ 5,000 total(indirect: By Spouse)Exp: 2018-06-12→ Common Stock (5,000 underlying) - Tax Payment
Common Stock
2017-06-12$0.36/sh−4,472$1,610→ 144,953 total - Exercise/Conversion
Common Stock
2017-06-12+9,375→ 149,425 total - Exercise/Conversion
Restricted Stock Unit (RSU)
2017-06-12−9,375→ 9,375 totalExp: 2018-06-12→ Common Stock (9,375 underlying)
Footnotes (4)
- [F1]Represents shares of common stock acquired upon settlement of the restricted stock units ("RSUs") listed in Table II.
- [F2]Represents shares of common stock that have been withheld by the issuer to satisfy the tax liability in connection with the settlement of RSUs and does not represent a sale by the reporting person.
- [F3]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock at settlement.
- [F4]Pursuant to the terms of the RSU, 25% of the total shares underlying the RSU vest annually each anniversary of June 12, 2014, subject to the reporting person's provision of service to the issuer on each vesting date.
Documents
Issuer
ONCOGENEX PHARMACEUTICALS, INC.
CIK 0000949858
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000949858
Filing Metadata
- Form type
- 4
- Filed
- Jun 13, 8:00 PM ET
- Accepted
- Jun 14, 4:39 PM ET
- Size
- 13.3 KB